MACF1 links rapsyn to microtubule- and actin-binding proteins to maintain neuromuscular synapses by Oury J et al.
ARTICLE
MACF1 links Rapsyn to microtubule- and actin-
binding proteins to maintain neuromuscular synapses
Julien Oury1, Yun Liu2, Ana To¨pf3, Slobodanka Todorovic4, Esthelle Hoedt1, Veeramani Preethish-Kumar5, Thomas A. Neubert1, Weichun Lin2,
Hanns Lochmüller6,7,8,9, and Steven J. Burden1
Complex mechanisms are required to form neuromuscular synapses, direct their subsequent maturation, and maintain the
synapse throughout life. Transcriptional and post-translational pathways play important roles in synaptic differentiation and
direct the accumulation of the neurotransmitter receptors, acetylcholine receptors (AChRs), to the postsynaptic membrane,
ensuring for reliable synaptic transmission. Rapsyn, an intracellular peripheral membrane protein that binds AChRs, is
essential for synaptic differentiation, but how Rapsyn acts is poorly understood. We screened for proteins that coisolate with
AChRs in a Rapsyn-dependent manner and show that microtubule actin cross linking factor 1 (MACF1), a scaffolding protein
with binding sites for microtubules (MT) and actin, is concentrated at neuromuscular synapses, where it binds Rapsyn and
serves as a synaptic organizer for MT-associated proteins, EB1 and MAP1b, and the actin-associated protein, Vinculin. MACF1
plays an important role in maintaining synaptic differentiation and efficient synaptic transmission in mice, and variants in
MACF1 are associated with congenital myasthenia in humans.
Introduction
The neuromuscular synapse is a highly specialized junction,
which is formed by motor nerve terminals and skeletal muscle
fibers (Burden, 1998; Sanes and Lichtman, 2001). The synapse
controls the movement of all skeletal muscles, including the dia-
phragm muscle that is essential for respiration and life. Key to
rapid, robust, and reliable synaptic transmission, acetylcholine
receptors (AChRs), the muscle receptors for the neurotransmitter,
are highly enriched in the postsynaptic membrane (Fertuck and
Salpeter, 1976). The high density of synaptic AChRs, approaching
20,000 molecules/µm2, ensures that acetylcholine will bind and
activate a sufficient number of AChRs to reliably initiate a muscle
action potential and muscle contraction (Wood and Slater, 2001).
Although the neuromuscular synapse forms and functions before
birth in mice, the structure and function of the synapse is modi-
fied during the first few postnatal weeks, increasing the reliability
of neuromuscular transmission, and then maintained throughout
life (Slater, 1982; Wood and Slater, 2001; Tintignac et al., 2015).
Two signaling pathways, one transcriptional and a second
post-translational, are necessary to form and maintain synapses,
ensuring that AChRs are expressed at a high concentration in the
postsynaptic membrane (Burden, 1998; Sanes and Lichtman,
2001; Wu et al., 2010). The transcriptional pathway occurs se-
lectively in myofiber nuclei situated near the synaptic site,
termed subsynaptic nuclei, and stimulates the expression of key
genes, which encode for proteins that are essential to build and
maintain the synapse (Burden, 1993; Schaeffer et al., 2001). The
post-translational pathway acts to redistribute and anchor
AChRs, as well as other key muscle-derived proteins, at the
postsynaptic membrane (Burden, 1998; Sanes and Lichtman,
2001; Wu et al., 2010; Tintignac et al., 2015). Both pathways
require Agrin, which is secreted by motor nerve terminals
(McMahan, 1990; Gautam et al., 1996), as well as Lrp4, the
muscle receptor for Agrin (Kim et al., 2008; Zhang et al., 2008).
Agrin-binding to Lrp4 leads to activation of MuSK, the trans-
ducing receptor tyrosine kinase (Burden et al., 2013), leading to
recruitment of Dok-7, a cytoplasmic adaptor protein that assists
in activating MuSK and also functions downstream from MuSK
(Yamanashi et al., 2012; Burden et al., 2013). In contrast to these
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core components, which function both in the synapse-specific
transcriptional pathway and the post-translational anchoring
pathway, Rapsyn, a 43-kd peripheral membrane protein that
binds to the main intracellular loop in the AChRs subunits, is
crucial for anchoring AChRs in the postsynaptic membrane but
does not act in the transcriptional pathway (Sobel et al., 1978;
Neubig et al., 1979; Burden et al., 1983; Gautam et al., 1995; Banks
et al., 2003).
In addition to their roles in forming synapses, each of these
synaptic proteins is also essential for maintaining neuromus-
cular synapses, as inactivation of these genes in adult mice leads
to synaptic disassembly (Li et al., 2018). Consistent with these
findings, autoantibodies to MuSK, found in a subset of in-
dividuals with myasthenia gravis, cause neuromuscular dys-
function, demonstrating that these pathways also function
throughout life in humans (Koneczny et al., 2014; Gilhus and
Verschuuren, 2015). Moreover, in humans, hypomorphic muta-
tions in any one of these key genes are responsible for congenital
myasthenia (CM), a heterogeneous group of neuromuscular
diseases characterized by muscle weakness and fatigue (Engel
et al., 2015).
Although these core molecules are required both for forming
and maintaining synapses, there is evidence that a distinct set of
molecules selectively regulates the postnatal transition in
structure and function of the neuromuscular synapse (Tintignac
et al., 2015; Li et al., 2018). For example, α-Dystrobrevin, a
component of the dystroglycan complex, is not required for
synapse formation but plays an important role in synaptic
maturation (Grady et al., 2000).
The molecules and mechanisms that act downstream from
MuSK and regulate synaptic differentiation, including clustering
of AChRs, during development and later during synaptic matu-
ration are poorly understood. Very few proteins, namely, Rap-
syn, Src-family kinases, and APC, have been reported to bind
directly to AChRs (Sobel et al., 1978; Fuhrer and Hall, 1996;
Bartoli et al., 2001; Wang et al., 2003). As described above,
Rapsyn has an essential role in forming and maintaining neu-
romuscular synapses, while Src-family kinases, similar to
α-Dystrobrevin, play a role only later in synaptic differentiation
(Smith et al., 2001). Rapsyn was identified as an AChR-
associated protein nearly 40 yr ago (Sobel et al., 1978; Neubig
et al., 1979), but surprisingly little is known about how Rapsyn
functions to anchor postsynaptic proteins (Li et al., 2016, 2018).
Our poor understanding of Rapsyn function is due in part to
difficulties in purifying soluble and well-folded Rapsyn, im-
peding knowledge of its structure and understanding how
Rapsyn mediates synaptic differentiation. Moreover, few pro-
teins are known to bind directly to Rapsyn, and two Rapsyn-
interactors, α-Actinin and β-Catenin, have important roles in
skeletal muscle differentiation and function, complicating study
of their potential role at neuromuscular synapses (Zhang et al.,
2007a; Dobbins et al., 2008; Li et al., 2008). We sought to
identify additional Rapsyn-associated proteins in the hope that
study of their function would lead to insights into the mecha-
nisms by which Rapsyn regulates synaptic differentiation.
We performed a biochemical screen to identify proteins that
associate with Rapsyn by isolating AChRs from skeletal muscle
and using mass spectrometry (MS) to compare the protein
composition of the AChR complex isolated from WT and Rapsyn
mutant muscles. These experiments identified proteins that
require Rapsyn for their association with AChR. Here, we de-
scribe one such protein, microtubule actin cross linking factor
1 (MACF1), a 650-kD scaffolding protein that contains spectrin-
like repeats as well as binding sites for microtubules (MTs) and
actin (Suozzi et al., 2012; Zhang et al., 2017). MACF1 (also known
as ACF7) regulates MT and actin dynamics in epithelial cells as
well as the shape and position of nuclei in muscle and additional
cell types (Brown, 2008; Wang et al., 2015; Escobar-Aguirre
et al., 2017).
A yeast two-hybrid screen had identifiedMACF1 as a Rapsyn-
interacting protein over 10 yr ago (Antolik et al., 2007), but it
remained unclear whether MACF1 was present at synapses and
whether MACF1 had a role in synaptic differentiation and
function. We demonstrate that MACF1 is concentrated at the
postsynaptic membrane at neuromuscular synapses, where it
serves as a synaptic scaffold and organizing center for MT-
associated proteins, including End-binding protein 1 (EB1) and
MT-associated protein 1b (MAP1b), as well the actin-associated
protein, Vinculin. We show that MACF1 plays an important role
in maintaining differentiation of neuromuscular synapses, effi-
cient synaptic transmission, and motor performance in adult
mice. In addition, in the absence of MACF1, the structure of the
sarcoplasmic reticulum (SR) and mitochondria are perturbed,
suggesting a role for MACF1, separate from its role at the syn-
apse, in skeletal muscle. Further, we show that two patients
diagnosed with CM carry missense changes in MACF1, suggest-
ing that these variants in MACF1 cause CM in humans.
Results
MACF1 coisolates with AChRs in a Rapsyn-dependent manner
We performed a biochemical screen to identify proteins that
associate with AChRs in a Rapsyn-dependent manner. We iso-
lated AChRs from skeletal muscle tissue of WT or Rapsyn−/−
mice, as well as from immortalized muscle cell lines derived
fromWT or Rapsyn−/−mice. AChRs and associated proteins were
isolated using biotin-conjugated α-bungarotoxin (α-BGT), which
binds tightly and specifically to AChRs, and streptavidin-agarose
beads (Fig. 1 A). Proteins that coisolated with AChRs were
identified by liquid chromatography (LC)/MS, and their abun-
dance was quantified by measuring the mass spectral signal
intensity of the identified tryptic peptides, the number of
identified peptides, and the percentage of sequence coverage for
each protein (Table S1). We performed two control experiments
to ensure that each identified protein coisolated specifically with
AChRs: (1) biotin-conjugated α-BGT was omitted from the iso-
lation scheme, or (2) AChRs were saturated with unlabeled
α-BGT before incubation with biotin-conjugated α-BGT. Pro-
teins that were recovered in the absence of biotin-conjugated
α-BGT binding were considered to bind nonspecifically to the
streptavidin-agarose resin.
As expected, AChR subunits were isolated from WT and
Rapsyn mutant cells at similar levels, and we therefore nor-
malized the abundance of all other proteins to the level of AChR
Oury et al. Journal of Cell Biology 1687
MACF1, a scaffold at neuromuscular synapses https://doi.org/10.1083/jcb.201810023
subunits (Fig. 1 B and Table S1). Yeast two-hybrid studies had
identified four Rapsyn partners, including Calpain, α-Actinin,
β-Catenin, and MACF1 (Antolik et al., 2007; Chen et al., 2007;
Zhang et al., 2007a; Dobbins et al., 2008). The MS data con-
firmed that all four proteins coisolate with AChRs in a Rapsyn-
dependent manner (Fig. 1 B and Table S1). In addition to these
Figure 1. MACF1 coisolates with AChRs in a Rapsyn-dependent manner. (A) The cartoon illustrates the procedure for isolating proteins that depend on
Rapsyn for their coisolation with AChRs. (B) The proteins that associated with AChRs in a Rapsyn-dependent manner were 3- to 12-fold more abundant in
AChR complexes isolated fromWT than Rapsynmutant muscle cells. The mean ± SEM values from six independent experiments are shown (*, P < 0.05; **, P <
0.005; ***, P < 0.0005; ****, P < 0.00005). (C)MACF1 coisolates with AChRs in a Rapsyn-dependent manner. (D)MACF1 (green) colocalizes with AChRs (red)
and Synapsin (cyan) in cross-sections of innervated adult tibialis anterior muscle. MACF1 staining persists at denervated synaptic sites. Bar, 5 µm. (E) The
cartoon illustrates that presynaptic Synapsin is separated by postsynaptic AChRs by >50 nm. As such, the positions of AChRs (red) and Synapsin (cyan) can be
resolved in optical sections of the neuromuscular synapse. MACF1 (green) is present at the AChR-rich postsynaptic membrane (red) and not in nerve terminals.
Bar, 2 µm. Colocalization of AChRs with Rapsyn (0.873 ± SEM 0.004), MACF1 (PCC = 0.750 ± SEM 0.021), and Synapsin (PCC = 0.341 ± SEM 0.021) were
determined using PCC.
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known Rapsyn partners, we identified nine proteins that asso-
ciated with AChRs in a Rapsyn-dependent manner both in
skeletal muscle tissue and in a muscle cell line (Fig. 1 B and Table
S1). These proteins were 3- to 12-fold more abundant in AChR
complexes isolated from WT than Rapsyn mutant muscle cells
(Fig. 1 B and Table S1). In each instance, restoring Rapsyn ex-
pression in Rapsynmutant cells rescued their normal association
with AChRs (data not shown). The newly identified Rapsyn-
dependent partners included Integrin α7, XIRP1, Titin, MAP1b,
Nebulin, α-Catenin, TOP2β, ARMS, and NCAM (Fig. 1 B and
Table S1). Earlier studies reported that ITGA7 and ARMS are
expressed at neuromuscular synapses (Martin et al., 1996;
Burkin et al., 1998; Luo et al., 2005), and we confirmed the
presence of ITGA7, and ARMS, as well as TOP2β at neuromus-
cular synapses by immunostaining (Fig. S1). The function of
these proteins, as well as the known Rapsyn-interacting protein
at neuromuscular synapses, is poorly understood, in large part
because their in vivo function at synapses has not been in-
vestigated. Because MACF1 is a scaffolding protein, containing
domains that can associate with MT- as well as actin-based fil-
ament systems, which have been implicated in synaptic differ-
entiation, we chose to study MACF1 further.
MACF1, a member of the Spectraplakin family of proteins
that cross-link MTs and actin, contains CH1 and CH2 domains
near the amino terminus, which serve as binding sites for actin,
and a binding site for EB1, a MT end-binding protein, near the
carboxy terminus (Suozzi et al., 2012; Zhang et al., 2017). A
Plakin domain and multiple Spectrin-like repeats are contained
between the actin- and MT-binding regions, yielding a rod-like,
650-kD molecule that assists in stabilizing MT- and actin-
associated filament systems (Suozzi et al., 2012; Zhang et al.,
2017). The yeast two-hybrid study demonstrated that the
actin-binding domain in MACF1 binds the tetratricopeptide re-
peats in Rapsyn (Antolik et al., 2007).
To confirm the findings from our MS studies, we isolated
AChRs from muscle of WT and Rapsyn−/− embryos and probed
Western blots with antibodies to MACF1, Rapsyn, and the AChR
β-subunit. Fig. 1 confirms that Rapsyn is required for MACF1 to
coisolate with AChRs (Fig. 1 C). In addition, we stained cross-
sections of skeletal muscle with antibodies to MACF1, AChRs,
and Synapsin, a synaptic vesicle protein present in presynaptic
motor nerve terminals, and found that MACF1 is concentrated at
neuromuscular synapses in innervated and denervated muscle,
demonstrating thatMACF1 is a postsynaptic protein (Fig. 1 D). To
determine whether MACF1 is additionally expressed in nerve
terminals, we optically sectioned neuromuscular synapses from
stained whole mounts of muscle, which demonstrated that
MACF1 is present at the postsynaptic membrane but is not de-
tectable in motor nerve terminals (Fig. 1 E).
MACF1 is not essential for neuromuscular synapse formation
We next sought to determine the role that MACF1 might play at
neuromuscular synapses. Macf1−/− mice die at gastrulation,
precluding analysis of neuromuscular synapse formation (Chen
et al., 2006). To conditionally inactivateMacf1 in skeletal muscle,
we generated mice that carried null and floxed alleles of Macf1
and a transgene in which Cre recombinase expression was
controlled by the regulatory region from the human skeletal
muscle actin (Hsa) gene. The floxed allele of Macf1 contains loxP
sites flanking exons 6 and 7, which encode the actin-binding
domain in MACF1, leading to a frame shift and premature
truncation of MACF1 (Wu et al., 2008). Mice carrying two floxed
alleles of Macf1 (Macf1f/f) were crossed with mice that were
heterozygous forMacf1 and carried the Hsa::Cre transgene (Hsa::
Cre; Macf1+/−), generating the conditionally mutant and control
mice. Hsa::cre; Macf1f/- mice were recovered postnatally at the
expectedMendelian ratio (Fig. 2 A), indicating thatMACF1 is not
essential in skeletal muscle for the formation and function of
neuromuscular synapses, which are required for respiration and
survival at birth. We quantified the loss of MACF1 by measuring
the amount of MACF1 in muscle tissue lysates and in complex
with AChRs. Because muscle tissue contains multiple cell types
and MACF1 is widely expressed, the amount of MACF1 associ-
ated with AChRs provides a better estimate of the reduction in
MACF1 expression specifically in myofibers. MACF1 levels were
reduced more than 10-fold in muscle tissue, and MACF1 was
undetectable in AChR complexes from Hsa::Cre; macf1f/− mice,
indicating that MACF1 is efficiently removed from myofibers in
Macf1 muscle-conditional mutant mice (Fig. 2 B). Further, we
confirmed the loss of MACF1 from synapses by immunostaining
muscle fibers from Hsa::Cre; Macf1f/− mice (Fig. 2 C).
During development, motor axons branch and terminate in a
band of synapses that are adjacent to the main intramuscular
nerve. Each muscle fiber is innervated at a single synaptic site,
which is marked by the accumulation of synaptic vesicles in
nerve terminals and a high concentration of AChRs in the
postsynaptic membrane (Sanes and Lichtman, 2001). To deter-
mine whether MACF1 has a role in organizing presynaptic and
postsynaptic differentiation, we analyzed whole mounts of dia-
phragm muscles from embryonic day 18. 5 (E18.5) mice, 4 to 5 d
after synapses first form, by staining with probes that mark
motor axons, nerve terminals, and AChRs. Neuromuscular
synapses, shaped as ovoid plaques of AChRs that are apposed by
motor nerve terminals, form in Hsa::Cre; Macf1f/−mice (Fig. 3 A).
Although major features of synapse formation occurred nor-
mally in mice deficient inMACF1 muscle expression, the density
of synaptic AChRs was reduced by 13% (Fig. 3 B). Consistent with
these findings, although the number and size of AChR clusters
induced by Agrin were normal inMacf1mutant myotubes grown
in cell culture, the density of AChRs in these clusters was re-
duced by 29% (Fig. S2). Thus, MACF1 participates but is not
essential for early steps in postsynaptic differentiation.
The postnatal morphological maturation of neuromuscular
synapses is impaired in mice lacking MACF1 in muscle
Once formed, neuromuscular synapses mature over a 3-wk
postnatal period. During this maturation period, synaptic size
increases by four- to fivefold, and the ovoid plaque-like ar-
rangement of AChRs is transformed and sculpted to generate a
pretzel-like shape with a nearly contiguous arrangement of
AChRs that is maintained throughout life (Fig. 3 C). Thereafter,
synaptic size increases more modestly, while the density of
synaptic AChRs, established by birth, ismaintained (Slater, 1982;
Fig. 3 D). To determine whether MACF1 is required for this
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postnatal structural reorganization, we quantified synaptic size,
as described above, and fragmentation, a feature often observed
at diseased synapses, by measuring the number of contiguous
AChR-stained units at each synapse. In Macf1 conditionally
mutant mice, like Macf1f/+ control mice, nerve terminals re-
mained reliably aligned and apposed to AChRs (Fig. 3 D).
Moreover, synaptic size increased normally in Macf1 condition-
ally mutant mice from E18.5 to postnatal day 30 (P30; Fig. 3 D).
Thereafter, however, synaptic size failed to increase further in
Macf1 muscle-conditionally mutant mice (Fig. 3 D). Moreover,
Macf1 mutant synapses became fragmented after P30, and the
extent of fragmentation increased over the next several months
(Fig. 3 D). The density of synaptic AChRs, already reduced at
birth, remained diminished and reduced by nearly 20% from
P30 through P180 (Fig. 3 D). Thus, MACF1 is required for the
morphological maturation and maintenance of neuromuscular
synapses.
In addition, we examined neuromuscular synapses in older
mice to learn whether the deficits, evident at P180, persisted or
worsened with age. We studied muscle from mice at 1 yr of age
and found that synaptic size and synaptic AChR density re-
mained diminished and excessive synaptic fragmentation per-
sisted (Fig. 3 D). Moreover, these deficits were apparent in
multiple limbmuscles as well as the diaphragmmuscle (Fig. S3).
These data further demonstrate that MACF1 is required to
maintain neuromuscular synapses in adult mice.
Macf1muscle-conditional mutant neuromuscular synapses are
functionally impaired
Muscle fibers become atrophic as muscle use is diminished. We
wondered whether the morphological changes at the neuro-
muscular synapse inMacf1mutant mice might lead to decreased
muscle activity and cause a reduction in muscle fiber size. Fig. 4
A shows that muscle fiber size was normal in Macf1 muscle-
conditional mutant mice at P30, when synaptic morphology
appeared normal. However, by P180, when morphological
changes at the synapse were evident (Fig. 3, C and D), muscle
fibers inMacf1mutant mice were atrophic, as the cross-sectional
area of muscle fibers decreased by 30% (Fig. 4 A).
We measured the number of muscle fibers and the number of
myofibers with central nuclei to determine whether myofibers
were lost or showed signs of degeneration/regeneration. Fig. 4 B
shows that the number ofmyofibers is unchanged inMacf1mutant
mice (Fig. 4 B). Nonetheless, a low level of muscle degeneration/
regeneration is evident in Macf1 mutant mice (Fig. 4 C), as 1% of
myofibers in control mice and 3–5% of myofibers inMacf1mutant
mice have centrally located nuclei at P180 and P365, respectively.
We used electron microscopy to study the ultrastructure of
muscle inMacf1mutantmice and learn whether the organization
of sarcomeres or myofibrils was altered. Fig. 4 D shows that the
general organization of muscle, notably the registered alignment
of Z-discs, A-bands and I-bands, as well as the presence of triads,
formed by transverse tubules (T-tubules) and sarcoplasmic
Figure 2. MACF1 is efficiently inactivated in
skeletal muscle using a Human skeletal actin
(Hsa)::Cre transgene. (A) We determined the
genotype of the progeny at P5–P10. χ2 analysis
of progeny from a cross of Macf1f/f mice with
Hsa::Cre; Macf1+/− mice shows that the occur-
rence of genotypes is unlikely to occur by
chance, indicating that mice lacking MACF1 in
muscle survive postnatally. (B) MACF1 expres-
sion is reduced by 14-fold in muscle lysates and
undetectable (reduced by >98%) in AChR com-
plexes isolated from Macf1 conditionally mutant
mice. The mean ± SEM values from three inde-
pendent experiments are shown (**, P < 0.005;
***, P < 0.0005). (C) Antibody staining shows
that MACF1 (green) is enriched at synapses,
marked by staining for AChRs (red), in Macf1f/+
control mice but absent from synapses in Hsa::
Cre; Macf1f/− mice. The striated, sarcomeric
staining is nonspecific, as this staining persists in
Macf1 mutant mice. Bar, 10 µm.
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reticulum (SR), appeared normal in the absence of MACF1.
However, the SR appeared distended, ranging from modestly to
severely enlarged, and a subset of mitochondria showed signs of
damage. Together, these findings indicate that the structures of
the SR and mitochondria are perturbed in the absence of MACF1
in ways that are unlikely to be a consequence of the synaptic
defects (Fig. 4 D). Although we do not know how MACF1 regu-
lates the structure of the SR and mitochondria, changes in their
function may contribute to the muscle atrophy and diminished
muscle function in Macf1 mutant mice (see below).
We next evaluated the motor performance of Macf1 muscle-
conditional mutant mice in order to more directly determine
Figure 3. The postnatal morphological mat-
uration of the neuromuscular synapse is im-
paired in mice lacking MACF1 in muscle. (A)
Diaphragm muscles from Macf1f/+ control and
Hsa::Cre; Macf1f/− mice at E18.5 were stained
with Alexa Fluor 488–α-BGT to label AChRs (red)
and antibodies to Neurofilament/Synapsin to
label motor axons/nerve terminals (green). Bar,
50 µm. (B) The size of the synapse, the density
of synaptic AChRs, and percent of AChR-rich
areas that are apposed by nerve terminals
were quantified. At E18.5, synaptic size is normal,
but the density of synaptic AChRs is reduced by
13% in Macf1 mutant muscle. The mean ± SEM
values from three mice (100 synapses per
mouse) are shown (***, P < 0.0005). (C) At P90,
neuromuscular synapses in Macf1 muscle-
conditional mutant mice show signs of deterio-
ration. Synapses, marked by staining for AChRs
(red), are smaller in size, and their pretzel-like
shape is less elaborate. Bar, 10 µm. (D) Neuro-
muscular synapses in Macf1 muscle-conditional
mutant mice deteriorate further, as synaptic
size fails to increase between P90 and P365, and
the extent of synaptic fragmentation worsens in
Macf1 mutant mice. Moreover, the density of
synaptic AChRs is reduced by 20%. The mean ±
SEM values from three mice (100 synapses per
mouse) are shown (*, P < 0.05; **, P < 0.005;
***, P < 0.0005; ****, P < 0.00005).
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whether muscle function was impaired in Macf1 mutant mice.
We measured body weight, limb grip strength, and behavior on
an accelerating rotarod at P90 and P180. Fig. 5 A shows that the
motor performance of male and female Macf1 mutant mice was
impaired, as their limb grip strength was reduced by 25%, and
their performance on the rotarod was similarly diminished at
P180 (Fig. 5 A). Together, these findings suggest that alterations
in synaptic structure, the function of the SR and mitochondria,
or a combination of these deficits is responsible for the de-
creased muscle use and muscle atrophy.
We used intracellular microelectrodes to record synaptic
activity to learn whether synaptic transmission was impaired in
Figure 4. Muscle fibers are atrophic and show aberrations in the structure of the SR and mitochondria in Macf1 mutant mice. (A) Cross-sections of
P30, P180, and P365 tibialis anterior muscles were stained with hematoxylin and eosin. The cross-sectional area (CSA) of myofibers is reduced by 30% in Hsa::
Cre; Macf1f/− mice at P180 and P365. The mean ± SEM values from three mice (100 myofibers per mouse) are shown (***, P < 0.0005). Bar, 50 µm. (B) The
number of myofibers is normal inMacf1mutant mice. The mean ± SEM values from three mice (measured area: 40,000 µm2) are shown. (C)Macf1mutant mice
exhibit a low level of muscle degeneration/regeneration. 1% of myofibers in control mice and 3–5% of myofibers in Macf1 muscle-conditional mutants have
centrally located nuclei (arrow). The mean ± SEM values from three mice (100 myofibers per mouse) are shown (***, P < 0.0005, ****, P < 0.00005). Bar,
10 µm. (D) The organization of sarcomeres, Z-discs, and T-tubule/SR triads (arrowhead) appears normal in the absence of MACF1. InMacf1mutant mice, the SR
(white arrow) is distended, ranging frommodestly to severely enlarged, and a subset of mitochondria (*M) shows signs of damage. Bar, 1 µm for the left images
and 500 nm for the right images.
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Macf1 mutant mice. The frequency of miniature endplate po-
tentials (mEPPs) in the lumbrical muscle was reduced by 25%,
while the mEPP amplitude was increased by 25% (Fig. 5 B). The
25% decrease in mEPP frequency is likely attributed to the
similar decrease in synaptic size (Kuno et al., 1971). MEPP am-
plitude is determined in part by the number of AChR channels
that open in response to acetylcholine, the conductance prop-
erties of individual AChRs, and the input resistance of the
muscle fibers, which is inversely correlated with muscle fiber
size (Katz, 1966). The 20% decrease in density of synaptic AChRs
should result in a similar decrease in mEPP amplitude, and the
30% decrease in muscle fiber size is predicted to lead to a 40%
increase in input resistance and mEPP amplitude (Katz and
Thesleff, 1957). Together, the decreases in AChR density and
muscle fiber size are calculated to produce a 20% increase in
mEPP amplitude, close to the recorded value (Fig. 5 B). Thus,
synaptic transmission is impaired in a manner that corresponds
closely to the value calculated from the decreased density of
synaptic AChRs and size of the atrophic muscle fibers.
We stimulated the plantar nerve to the lumbrical muscle and
recorded evoked endplate potentials (EPPs) from individual
myofibers, which revealed a nearly 20% decrease in quantal
content, a measure of presynaptic release properties, including
synaptic size (Fig. 5 C). Thus, synaptic transmission is impaired
inmice lacking muscle-derivedMACF1, which likely contributes
to the decreased motor performance and muscle fiber atrophy.
MACF1 anchors MAP1b and EB1 at the postsynaptic membrane
at neuromuscular synapses
MACF1 binds EB1 and thereby serves as a scaffold for MTs and
MT-binding proteins (Suozzi et al., 2012; Zhang et al., 2017).
Consistent with this role, we identified MAP1b in our MS screen
of AChR-associated proteins (Fig. 1 B and Table S1), suggesting
that MAP1b and possibly EB1 may be concentrated at neuro-
muscular synapses in a manner that depends on MACF1. We
isolated AChRs from muscle of WT, Macf1f/+ control mice, Macf1
conditionally mutant mice, and Rapsynmutant mice and probed
Western blots with antibodies to MAP1b. MAP1b coisolates with
AChRs from WT and Macf1f/+ control muscles but not from
muscle lacking MACF1 (Fig. 6 A) or Rapsyn (Fig. S4). In contrast,
Rapsyn, as well as Rapsyn-associated proteins, including
β-Catenin, α-Actinin, and Calpain, associate with AChRs inde-
pendent of MACF1 (Fig. 6 A). These results indicate that MACF1
plays an important role in recruiting a MT network, including
MAP1b, to the postsynaptic membrane at neuromuscular syn-
apses. Moreover, these findings indicate that Rapsyn anchors
additional proteins, including certain components of the actin
network, independent of MACF1.
We stained neuromuscular synapses with antibodies to
MAP1b, as well as EB1 and β-Tubulin (β-TUB), to further study
expression of the MT network at synapses inMacf1 conditionally
mutantmice. In addition, we stained synapses with antibodies to
Vinculin, an actin-associated protein that is enriched at the
postsynaptic membrane at neuromuscular synapses (Bloch
and Hall, 1983), to determine whether MACF1 is required for
the enrichment of this actin-binding protein at the postsyn-
aptic membrane. Optical sectioning of stained neuromuscular
synapses shows that MAP1b, EB1, β-TUB, and Vinculin are
present both in presynaptic nerve terminals and at the postsynaptic
membrane in Macf1f/+ control mice (Fig. 6 B). In the absence of
muscle-derived MACF1, MAP1b, EB1, β-TUB, and Vinculin re-
main in presynaptic nerve terminals, but their expression at the
postsynaptic membrane is absent (Fig. 6, B and D). In contrast,
the complex grid-like arrangement of MTs in the nonsynaptic
region of muscle appears unperturbed in the absence of MACF1
(Fig. 6 C), suggesting that the aberrations in the SR and mito-
chondria of Macf1 mutant mice are not due to major changes in
the MT lattice. Thus, expression of MAP1b, EB1, β-TUB, and
Vinculin at the postsynaptic membrane depends on MACF1.
MACF1 is a synaptic podosomal protein
Myotubes that are grown in cell culture on Laminin-coated
substrates develop AChR clusters that are perforated and form
complex shapes, resembling the changing shapes of synapses
found during postnatal synaptic maturation (Kummer et al.,
2004). The AChR-poor perforations within these AChR clus-
ters contain proteins found in the core and cortex of podosomes,
dynamic, actin-rich, adhesive structures (Proszynski et al.,
2009). Inhibition of Src family kinases leads to disassembly of
the synaptic podosomes and disruption in the organization of
AChRs, consistent with the idea that podosomal proteins pro-
mote the remodeling in the arrangement of AChRs during
postnatal development (Proszynski et al., 2009). Because MACF1
has a role in maintaining the elaborate, pretzel-like shape of the
synapse, we reasoned that MACF1 might be a component of
synaptic podosomes. We therefore stained C2C12 myotubes,
grown on a Laminin matrix, for AChRs, MACF1, and podosomal
proteins. Fig. 7 shows that MACF1 is present in synaptic podo-
somes, where it colocalizes with core podosomal proteins, such
as F-actin, and is excluded from the cortex of the podosome,
marked by Vinculin (Fig. 7, A and B).We also stained for theMT-
associated proteins, MAP1b and EB1, and found that MAP1b and
EB1 colocalize with MACF1 within the core of synaptic podo-
somes (Fig. 7 C).
Synaptic podosomes represent a model for the transitional
period when synapses convert from a plaque- to a pretzel-like
shape. Because MACF1 colocalizes with MT-associated proteins
and not with Rapsyn and AChRs in synaptic podosomes, the
association of MACF1 may shift from a primary association with
MTs to an additional association with Rapsyn during this tran-
sitional period, directing MACF1 to the postsynaptic membrane.
The structure and function of MACF1 is regulated by association
of MACF1 with actin, which stimulates an intrinsic ATPase ac-
tivity in MACF1, directing MTs to focal adhesions in epithelial
cells (Wu et al., 2008). These findings raise the possibility that
changes in the structure and activity of MACF1 may occur as the
shape of AChR clusters transitions from a plaque to a pretzel-like
shape, as modeled in synaptic podosomes, redirecting MACF1 to
different binding partners, including Rapsyn.
Muscle fiber nuclei are enriched in the synaptic region of
Macf1-conditional mutant mice
Individual, adult myofibers contain several hundred nuclei. A
subset, ∼1%, of these nuclei is positioned and concentrated
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Figure 5. Synaptic transmission and motor performance are impaired in Macf1 muscle-conditional mutant mice. (A) Motor performance of male and
female Macf1 muscle-conditional mutant mice was impaired at P180, as assessed by grip strength and rotarod assays. The body weight of Macf1 mutant mice
was normal. The mean ± SEM values frommore than five mice are shown (*, P < 0.05; **, P < 0.005; ***, P < 0.0005). (B) The frequency of mEPPs was reduced
and the mEPP amplitude was increased in P180 Macf1 muscle-conditional mice. The mean ± SEM values from four mice are shown. (C) Quantal content was
reduced by 20% inMacf1muscle-conditional mutant mice. The mean ± SEM values from four mice are shown (**, P < 0.005). The rise time and half width of the
EPP were normal in Macf1 mutant mice. Likewise, the muscle resting membrane potential was similar in Hsa::Cre; Macf1f/− (70.3 ± 1.3 mV, n = 4 mice, n = 37
myofibers) and Macf1f/+ control mice (71.2 ± 0.8 mV, n = 4 mice, n = 38 myofibers).
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Figure 6. MACF1 anchors actin and MT networks at the postsynaptic membrane at neuromuscular synapses. (A) MAP1b coisolates with AChRs in a
MACF1-dependent manner in P180 mice. Association between AChR and Rapsyn is not dependent on MACF1. The mean ± SEM values from three independent
experiments are shown (*, P < 0.05; ***, P < 0.0005). (B)MACF1 (green) is required for the accumulation of MAP1b, EB1, β-TUB, and Vinculin (each shown in
green) at the postsynaptic membrane of neuromuscular synapses, marked by staining for AChRs (red). We did not detect EB1 in the AChR complex by MS or
Western blotting, suggesting that the association between EB1 and MACF1 is labile. MAP1b, EB1, and β-TUB, unlike MACF1 or Vinculin, are also expressed in
nerve terminals, and their presynaptic expression is not dependent on muscle-derived MACF1. Rapsyn (green) is expressed exclusively at the postsynaptic
membrane independent of MACF1. Bar, 1 µm. (C)MACF1 is dispensable for organizing MTs, stained with antibodies to α-TUB (red), in a grid-like pattern in the
nonsynaptic regions of the tibialis anterior muscle. Bar, 20 µm. (D) MACF1 is necessary for concentrating MTs (green) in the postsynaptic region, marked by
AChRs (red). Bar, 10 µm.
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within the synaptic compartment of muscle fibers, which allows
these nuclei to respond to local synaptic signals and boost
transcription of genes that encode for synaptic proteins (Merlie
and Sanes, 1985; Burden, 1993; Schaeffer et al., 2001). Spec-
traplakins are known to regulate nuclear positioning (Wang
et al., 2015), so we wondered whether the positioning of syn-
aptic nuclei might be perturbed in Macf1 conditionally mutant
mice. We stained single, dissected myofibers from Macf1f/+
control and Macf1 conditionally mutant mice for AChRs, nerve
terminals, and nuclei, and analyzed optical sections of neuro-
muscular synapses (Grady et al., 2005). This procedure allowed
us to avoid counting Schwann cell nuclei and to selectively
quantify myofiber nuclei in order to determine whether the
arrangement of myonuclei was perturbed in muscle lacking
MACF1 (Fig. 8, A and B). Wemeasured the number of myonuclei
at each AChR-stained area and normalized the number of syn-
aptic nuclei to the postsynaptic area at 90 synapses in three
mice. Fig. 8 A shows that myonuclei accumulated in the
subsynaptic region of muscle from control and Macf1 mutant
mice. At P180, Macf1 mutant synapses are 32% smaller than
synapses in control mice (Fig. 3 D), and the number of sub-
synaptic myonuclei is similarly reduced, resulting in a compa-
rable number of synaptic nuclei, normalized to postsynaptic
membrane area, in control and Macf1 mutant mice (Fig. 8 A).
Concomitant with this reduction in the total number of sub-
synaptic nuclei, the number of myofiber nuclei in the nearby
perisynaptic region was increased by twofold in Macf1 mutant
mice. Together, these data indicate that MACF1 is dispensable
for anchoring subsynaptic nuclei and suggest that a subset of
“synaptic nuclei,” unopposed by nerve terminals, become posi-
tioned in the perisynaptic region.
Missense variants inMACF1 in humans are associated with CM
Mutations in genes that are essential for the formation and
function of neuromuscular synapses are responsible for CM, a
heterogeneous group of diseases that causes muscle weakness
Figure 7. MACF1 is a synaptic podosomal protein. (A) MACF1 (green) concentrates within perforations of AChR clusters (red). Bar, 10 µm. (B) Higher
magnification images show that MACF1 (green) is enriched in the core of synaptic podosomes, like F-actin (cyan) and not found at the cortex of the podosome,
marked by Vinculin (cyan). Bar, 1 µm. (C) Together with MACF1, MAP1b and EB1 (each shown in green) are enriched in the core of the synaptic podosome.
Rapsyn (green) is not found in the perforations but together with AChRs. Bar, 4 µm.
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and fatigue (Müller et al., 2007; Engel et al., 2015). We used
exome sequencing to learn whether mutations inMACF1might
be responsible for disease in patients diagnosed with CM. We
identified one patient from Serbia who carries heteroallelic
missense variants in residues that are conserved in mouse and
human MACF1. The first variant is within a small exon en-
coding part of the Plakin domain (Chr1: 39802863 c.5395A>G;
p.Thr1799Ala), and the second variant is within the adjacent
exon encoding the first Spectrin-like repeat domain (Chr1:
39818781 c.6622C>T; p.Leu2208Phe [ENST00000289893];
Fig. 9 A). Alternatively spliced transcripts encoding both
residues are expressed in skeletal muscle, heart muscle, whole
blood, and esophagus (https://gtexportal.org). Neither variant
has been seen in homozygosity in a control population of
>125,000 individuals (http://gnomad.broadinstitute.org/).
p.Thr1799Ala is predicted to be damaging by in silico
tools, SIFT (http://sift.bii.a-star.edu.sg/) and MutationTaster
(http://www.mutationtaster.org/), with a Combined Annota-
tion Dependent Depletion score of 21.6 (top 0.5% most dele-
terious variants). As expected, the unaffected parents carried
one allele of each variant and transmitted these two variants
to the patient, while the unaffected siblings carry only one
variant each (Fig. 9 B). No other pathogenic variants in genes
previously associated with myasthenic syndromes or other
neuromuscular disorders have been identified in this patient.
Clinical examination identified symptoms of ptosis, weakness
of extraocular muscles, weakness of neck flexors, weakness
and fatigue of tongue, and swallowing difficulties starting at 5
yr old (Fig. 9 C). Needle electromyography was normal with
no signs of nerve or muscle dysfunction, although the re-
sponse to repetitive stimulation at 3 Hz in proximal muscles
showed pathological decrement, indicating failure of neuro-
muscular transmission as typically found in myasthenic syn-
dromes (Fig. 9 C).
Figure 8. Muscle fiber nuclei are enriched in
the synaptic region of Macf1-conditional
mutant mice. (A) Myonuclei accumulate in the
subsynaptic region of muscle from control and
Macf1 mutant mice. The total number of sub-
synaptic myonuclei is reduced by 18% in Macf1
muscle-conditional mutant mice at P180. The
number of subsynaptic nuclei, normalized to
synaptic size, is increased by 22% in Macf1 mu-
tant mice. The number of nuclei in the peri-
synaptic region is increased by twofold. Synaptic
sites were marked by staining for AChRs (red),
and nuclei were stained with Hoechst 33342
(cyan). The mean ± SEM values from three mice
(30 synapses per mouse) are shown (**, P <
0.005; ***, P < 0.0005). A long arrow indicates a
subsynaptic nucleus, an arrowhead indicates a
perisynaptic nucleus, which is adjacent to the
synaptic site, and a short arrow indicates a
nonsynaptic nucleus. Bar, 10 µm. (B) We dis-
tinguished between nuclei of perisynaptic cells,
including Schwann cells, and myofiber nuclei by
optical sectioning of muscle tissue stained for
nuclei (cyan), AChRs (red) and Synapsin (green);
we only counted nuclei within the myofiber.
Bar, 5 µm.
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We then interrogated a database, which contains more than
3,000 exomes from rare disease patients, together with clinical
information from the RD-Connect genome phenome analysis
platform, in order to determine whether additional cases of CM
may be associated with variants in MACF1. By these means we
found a second CM patient with a homozygous MACF1 variant.
The missense variant (Chr1: 39801627 c.4687G>A; p.Val1563Met)
is located in a large exon encoding the majority of the Plakin
domain (Fig. 9 A). c.4687G>A is predicted to alter an exonic
splice enhancer and potentially result in abnormal splicing
(http://www.umd.be/HSF3/index.html). This variant has been
observed four times among 125,725 healthy control individuals
but never in homozygosity (http://gnomad.broadinstitute.org).
The patient, who does not carry pathogenic variants in other
myasthenia-associated genes, presented with late-onset fatiga-
ble weakness of the limb girdle musculature and mild, asym-
metric ptosis, without ophthalmoparesis. Similar to the Serbian
patient, recordings from the quadriceps, deltoid, and tibialis
anterior muscles in this Indian patient showed a pathological
decrement following stimulation at 3 Hz (Fig. 9 C). The patient
responded well to acetylcholinesterase inhibitors and salbuta-
mol. Together, these clinical findings are consistent with the
synaptic deficits found in mice deficient in muscle-derived
MACF1 and indicate that CM can be caused by mutations in
MACF1.
Discussion
Here, we show that MACF1 coisolates with AChRs in a Rapsyn-
dependent manner and recruits a MT network, including EB1
and MAP1b, as well as the actin-binding protein Vinculin, to the
postsynaptic membrane to regulate the maintenance of neuro-
muscular synapses. The loss of MACF1 does not recapitulate the
loss of Rapsyn, demonstrating that MACF1 does not mediate all
roles for Rapsyn, including the clustering of AChRs at synapses
during development. Instead, MACF1 plays a role in maintaining
neuromuscular synapses, in part by promoting the postnatal
growth of synapses and maintaining synaptic AChR density at
normal levels. These findings point to a distinction between
mechanisms and molecules to form neuromuscular synapses
and those required for the maintenance of synapses. Thus,
MACF1 joins Utrophin, Dystrobrevin, and Src-family kinases as
synaptic proteins that have selective roles in the postnatal
maturation andmaintenance of neuromuscular synapses (Grady
et al., 2000; Smith et al., 2001; Sadasivam et al., 2005). Impor-
tantly, our findings reveal that deficits in these later steps lead to
an impairment in synaptic transmission and motor performance
in mice and suggest that these deficits are a cause for CM in
humans.
Major features of synapse differentiation occur normally
during embryonic development and early postnatal life in
mice deficient in muscle expression of MACF1. Neuromuscular
Figure 9. Two patients diagnosed with congenital myasthenia carry alleles withmissense variants inMACF1. (A) Two missense variants ofMACF1were
identified in the Serbian patient diagnosed with CM. The first variant is found in a small exon encoding part of the Plakin domain (Chr1: 39802863 c.5395A>G;
p.Thr1799Ala), and the second variant is found in an exon encoding the first Spectrin repeat (Chr1: 39818781 c.6622C>T; p.Leu2208Phe; indicated in red). These
domains are interposed between the calponin-homology (CH) domain and the Gas2-related (GAR) domain. The Indian patient is homozygous for a MACF1
variant in a large exon encoding the bulk of the Plakin domain (Chr1: 39801627 c.4687G>A; p.Val1563Met; indicated in blue). (B) Each parent carried one variant
and transmitted this MACF1 variant to the patient; none of the unaffected siblings carried both MACF1 variants. In red: Samples submitted to whole exome
sequencing. (C) Clinical examination identified the indicated symptoms.
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synapses form in the central region of muscle and appear
normal in size and shape. However, even at early stages, the
density of synaptic AChRs is reduced by 13% in Macf1 muscle-
conditional mutant mice, indicating that MACF1 has a role,
though modest, at developing synapses. A failure to detect a
deficit in motor performance in young Macf1 mutant mice may
be due to the threefold excess of synaptic AChRs at neuro-
muscular synapses, which contributes to the safety factor for
synaptic transmission (Wood and Slater, 2001). Over the next
month, synaptic size increases and the shape of the synapse is
transformed from an ovoid plaque to a complex pretzel-like
shape in normal mice and mice deficient in muscle-derived
MACF1. However, after 1 mo, synaptic size fails to increase
further, and signs of deterioration, including synaptic frag-
mentation, become evident in Macf1 mutant mice.
In addition, a loss of MACF1 leads to distension of the SR and
aberrations in mitochondria. We do not know how MACF1
regulates the structure of the SR and mitochondria, but per-
turbations in SR or mitochondrial function, including calcium
homeostasis, may contribute to the muscle atrophy and de-
creased motor performance evident inMacf1mutant mice. These
perturbations may also contribute to the motor deficits of CM
patients carrying variants in MACF1.
In Drosophila melanogaster, Shot, the homologue of MACF1,
interacts with EB1 and MSP-300, a nuclear scaffold protein, and
the proteins play important roles in positioning myofiber nuclei
and stabilizing the shape of myonuclei during muscle contraction
(Wang et al., 2015). SYNE/Nesprin, themouse homologue ofMSP-
300, plays a similar role in positioning nuclei in muscle, including
the accumulation of myonuclei in the subsynaptic region (Grady
et al., 2005; Zhang et al., 2007b). SYNE-1 interacts with MuSK
(Apel et al., 2000), and this association may contribute to teth-
ering SYNE-1–decorated myonuclei in the synaptic region. Con-
sidering the findings in Drosophila, SYNE-1 may also associate
with MACF1, which is attached to Rapsyn. As such, redundant
mechanisms may function to tether SYNE-1–decorated nuclei in
the myofiber subsynaptic region: one mechanism mediated by
MACF1, which is attached to Rapsyn, and a second mediated by
MuSK, which binds directly to SYNE-1. Such redundancy would
provide a possible explanation for a near normal number of nuclei
in the synaptic region of Macf1 mutant mice.
MACF1 plays an important role in recruiting MTs and
MT-binding proteins, EB1 and Map1b, to neuromuscular syn-
apses. A second pathway for recruiting MTs to the postsynaptic
membrane is stimulated by Agrin and mediated by binding of
MTs to CLASP2/CLIP170, which are recruited to the postsynaptic
membrane by binding to LL5β (Schmidt et al., 2012; Basu et al.,
2015). The deficits in synaptic size and synaptic AChR density
appear similar in Clasp2 mutant and Macf1 muscle-conditional
mutant mice (Basu et al., 2015). Although Clasp2 mutant mice
failed to show gross deficits inmotor behavior (Basu et al., 2015),
it is unclear whether Clasp2 mutant mice have defects in syn-
aptic transmission or motor performance. Moreover, it is un-
clear whether the reduction in synaptic size, evident in Macf1
muscle-conditionally mutant mice only after P30, is apparent
in Clasp2 mutant mice throughout development or only after
synaptic maturation.
The CLASP2 and MACF1 pathways do not appear to act in a
redundant manner to recruit MTs and MT-binding proteins to
the neuromuscular synapse. Notably, MAP1b, EB1, and β-TUB
are lost from the postsynaptic membrane at neuromuscular
synapses in Macf1 muscle-conditionally mutant mice. These
findings suggest that CLASP2 is either absent or insufficient to
tether these proteins to the postsynaptic membrane in the ab-
sence of MACF1.
Elegant studies have demonstrated a deficit in transport and
insertion of AChR-containing secretory vesicles to the postsyn-
aptic membrane in Clasp2mutant mice (Basu et al., 2015), a role
previously proposed for synaptic MTs (Jasmin et al., 1990;
Marchand et al., 2002). Measurements of AChR synthesis will be
necessary to determine whether impairment of this synthetic
pathway contributes to the deficits found in Macf1 conditionally
mutant mice.
We provide evidence that several proteins, including ITGA7,
ARMS, and TOP2β, associate with AChRs in a Rapsyn-dependent
manner. Prior studies demonstrated that ITGA7 and ARMS are
concentrated at neuromuscular synapses (Martin et al., 1996;
Luo et al., 2005), but it was unclear how these proteins become
concentrated at synapses. Here, we show that their association
with AChRs depends on Rapsyn. Surprisingly, we find that
TOP2β, a nuclear protein known for its role in unknotting DNA
during cell division and assisting in transcription of long tran-
scripts (Wang, 2002; Ju et al., 2006; Austin et al., 2018), is also
found outside the nucleus and at the postsynaptic membrane.
Two different antibodies to TOP2β stain neuromuscular syn-
apses, and staining is absent in muscle-conditional Top2β mu-
tant mice, confirming that the antibodies recognize TOP2β.
These findings raise several interesting questions: (1) whether a
novel form of TOP2β is found outside the nucleus and at the
postsynaptic membrane, (2) whether TOP2β binds directly to
Rapsyn, (3) what role TOP2β plays at the postsynaptic mem-
brane, (4) whether postsynaptic TOP2β is associated with nu-
cleic acids, and (5) whether the catalytic activity of TOP2β is
required for its function at the synapse.
CM is a heterogeneous group of neuromuscular diseases,
often caused by recessive, hypomorphic mutations in genes that
are responsible for building neuromuscular synapses or for
the function of neuromuscular synapses. Mutations in these
genes, including AGRIN, LRP4, MUSK, DOK-7, RAPSYN, ACHR,
and CHAT, compromise synaptic transmission and lead to fati-
gable muscle weakness (Engel, 2018). We identified one patient
with CMwho carries two variants inMACF1 and a second patient
who is homozygous for a different MACF1 variant. An earlier
study identified a patient carrying a partial duplication of the
MACF1 gene, leading to a decrease in MACF1 expression and
presenting with diminished motor skills (Jørgensen et al., 2014).
Although this patient was diagnosed with a novel myopathy,
dubbed a “spectraplakinopathy type I” (Jørgensen et al., 2014),
our findings, showing that variants inMACF1 are associated with
CM, raise the possibility that the patient with the MACF1 partial
duplication exhibits synaptic deficits, typical for CM. Here, we
present a clinical case of CM in a patient carrying two variant
missense alleles ofMACF1. These findings suggest that mutations
inMACF1may lead to deficits in synaptic transmission andmotor
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performance in humans, like mice, and cause CM. The patients
were identified at 5 and 30 yr of age, comparatively late for a
diagnosis of CM when caused by mutations in genes, such as
RAPSYN or ACHR subunit genes, which have important roles in
synapse formation. The late appearance of symptoms is consis-
tent with a role for MACF1 in synaptic maturation and mainte-
nance. The patients exhibited ptosis, limb girdle weakness,
clinical fatigue, and a decrement in the muscle response to re-
petitive nerve stimulation. Surprisingly, defects in other organ
systems were not evident. Two variants are present in an exon
encoding the Plakin domain, and the second variant is present in
an exon encoding the first Spectrin-like repeat. Macf1 is alter-
natively spliced (Hu et al., 2016), and it is possible that the
variant forms are expressed from splice forms produced pref-
erentially by muscle.
Consistent with a role for MACF1 as a scaffold for both actin
and MT networks (Wu et al., 2008), we found that synaptic
expression of Vinculin, an actin-binding protein, is dependent
on MACF1. Thus, MACF1 serves as an organizing center at the
postsynaptic membrane for both MT- and actin-based filament
systems. Synaptic podosomes, which share features with syn-
apses that are transitioning from an immature to a mature
shape, contain MACF1, MT-associated proteins, and actin in
their core and Vinculin at the cortex. How these proteins be-
come rearranged as synapses mature and change shape is not
understood, but MACF1 may participate and coordinate this
reorganization.
Materials and methods
Mice
The following mice have been described previously: Rapsyn
mutant mice (Gautam et al., 1995; MMRRC015108-UCD, RRID:
MMRRC_015108-UCD); mice that carry a loxP-flanked allele of
Macf1 (Wu et al., 2008); mice that carry a loxP-flanked allele of
Top2β (Lyu and Wang, 2003); H2Kb-tsA58 transgenic mice (Jat
et al., 1991; IMSR CRL:237, RRID:IMSR_CRL:237); and Hsa::Cre
transgenic mice (Miniou et al., 1999). Mice, all maintained on a
C57BL6 background, were housed and maintained according to
Institutional Animal Use and Care Committee guidelines.
Growth of cultured skeletal muscle cells
C2C12 mouse muscle cells (ATCC CRL-1772, RRID:CVCL_0188)
were grown at 37°C in growth medium: DMEM containing 4.5 g/l
glucose, L-glutamine, and sodium pyruvate (Corning cellgro),
supplemented with 10% FBS (GemCell). Myoblast fusion and
myotube differentiation were induced when myoblasts were
70% confluent by switching to differentiation medium: DMEM
with 4.5 g/liter glucose and 1 mM L-glutamine, supplemented
with 2% heat-inactivated horse serum. Immortalized myoblasts
were isolated fromWT and Rapsynmutant embryos and grown
as described previously (Smith et al., 2001).
Isolation of AChR complexes
Whole leg muscles or immortalized muscle cells were homoge-
nized at 4°C in lysis buffer (50 mM sodium chloride, 30 mM
triethanolamine, pH 7.5, 50 mM sodium fluoride, 5 mM EDTA,
5 mM EGTA, 2 mM sodium orthovanadate, 1 mM benzamidine,
1 mM N-ethylmaleimide, 1 mM sodium tetrathionate, 5 µg/ml
leupeptide, 5 µg/ml aprotinin, and 10 µM pepstatin, plus com-
plete protease inhibitors; Roche). NP-40 was added to a final
concentration of 1%, and the extract was incubated with rocking
for 30 min at 4°C. In another experiment, we substituted digi-
tonin for NP-40 (Table S2). Insoluble proteins were removed by
centrifugation at 12,000 rpm for 20 min at 4°C. The supernatant
was precleared for 1 h at 4°C with streptavidin-agarose beads
(Sigma-Aldrich) before incubation for 1 h at 4°C with biotin–α-
BGT (10−8 M; α-BGT; Invitrogen). Biotin–α-BGT/AChR com-
plexes were incubated for 4 h with streptavidin-agarose beads.
The beads were subsequently washed (three times for 9 min) in
lysis buffer containing 1% NP-40. Proteins were eluted from the
beads with 1% SDS in lysis buffer.
MS
To identify the proteins that require Rapsyn for their association
with AChRs, we used skeletal muscle tissue from E18.5 WT and
Rapsyn−/− mice and immortalized muscle cell lines. We isolated
AChRs, as described above. To ensure that the isolated proteins
were bound specifically to the AChR, we performed two control
experiments. First, we omitted biotin–α-BGT from the incuba-
tion with cell lysates. As such, AChRs were unable to specifically
bind to the streptavidin-agarose beads. Second, we preincubated
cell lysates with a saturating dose (10−7 M) of unlabeled α-BGT
to block binding of biotin–α-BGT and prevent binding of AChRs
to the streptavidin-agarose beads. To confirm that the reduced
recovery of MACF1 from Rapsynmutant muscle was due to a loss
of Rapsyn, we restored Rapsyn expression in Rapsynmuscle cells
and confirmed by MS that restoring Rapsyn expression rescued
coisolation of MACF1 with AChRs (data not shown). AChR
complexes from WT and Rapsyn−/− mice and muscle cell
lines were allowed to briefly enter (5 min at 180 V) SDS-
polyacrylamide gels (4–12% acrylamide; Invitrogen). A single
gel slice containing the unseparated proteins was excised from
gels stained overnight with Coomassie blue, and the proteins
were digested using MS-grade trypsin (Promega). To identify
AChR partners, tryptic peptides were analyzed using nanoflow
LC/ESI-MS/MS with a Q-Exactive HF quadrupole-Orbitrap
coupled to a NanoEasy UPLC system (Thermo Fisher Scien-
tific) running a gradient of 3–90% acetonitrile in 0.1% formic
acid over 60 min (3–40% for 50 min, 40–90% for 5 min, and 90%
for 5 min) at a 250 nl/min LC flow rate. The following acquisi-
tion parameters were specified: resolution 120,000, AGC target
3e6, MS1 scan range 300–1,750 Th, profile mode. The collision
induced dissociation (MS2) parameters were as follows: top 15
data dependent acquisition (DDA) was selected, resolution was
set to 15,000, the automatic gain control (AGC) target was set to
1e6, injection time was limited to 60 ms, normalized collision
energy (NCE/stepped) was set to NCE 27, dynamic exclusion was
set to 30 s, and ions with charge 1 or unassigned were excluded.
Peptides were identified using MaxQuant/Andromeda version
(Cox et al., 2011) using standard parameters (Gauthier et al.,
2017) to search the Mouse fasta (date: 01092015, containing
16,699 protein sequences). Once identified, relative abundance
of proteins was determined by integrating the mass spectral
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signal intensity for the identified peptides. The number of
identified peptides and the percentage sequence coverage for
each protein were also used to confirm the intensity-based rel-
ative quantitation of proteins. We required the identification of
five or more peptides and sequence coverage greater than 4% to
consider a protein further. The relative abundance of each
identified protein based on spectral intensity was normalized to
the abundance level of AChR subunits, and the ratio of relative
protein abundance in AChR-bound complexes fromWT/Rapsyn−/−
muscle was calculated. MS data represent the mean values from
three experiments with muscle tissues and three experiments
with immortalized muscle cell lines. The Wilcoxon–Mann–
Whitney test was used to determine statistical significance and
was conducted using GraphPad Prism 6.0 software.
Western blotting
Proteins were fractionated by SDS-PAGE (6% or 8% acrylamide;
Invitrogen) and transferred to polyvinylidene fluoride mem-
branes. Blots were probed with antibodies to the AChR
β-subunit (N8283, RRID:AB_262151; Sigma-Aldrich), Rapsyn
(ab156002, RRID:AB_298028; Abcam), MACF1 (gift from R.
Liem, Columbia University Medical Center, New York, NY;
Chen et al., 2006), β-Catenin (ab32572, RRID:AB_725966; Ab-
cam), α-Actinin (ab18061, RRID:AB_444218; Abcam), Calpain
(ab28258, RRID:AB_725819; Abcam), or MAP1b (ab11266, RRID:
AB_297884; Abcam). We used antibodies to the AChR β-subunit
to ensure equal loading of proteins in whole-cell lysates and
proteins isolated with biotin–α-BGT. We quantified the band
intensities with a ChemiDoc imaging system (BioRad), as de-
scribed previously (Reme´dio et al., 2016). The band intensity for
each protein was indexed to the band intensity of the AChR
β-subunit, and the graphs show the mean values from three
separate experiments. The Wilcoxon–Mann–Whitney test was
used to determine statistical significance and was conducted
using GraphPad Prism 6.0 software.
Whole-mount muscle immunohistochemistry
Innervated and denervated hindlimb muscles from P60 mice
werefixed in 1% PFA (in PBS) for 1 h at 4°C, rinsed twice at 4°C in
PBS, cryoprotected overnight at 4°C (in PBS with 30% sucrose),
and embedded in TissueTek (Sakura). Frozen sections (10 µm)
were stained with antibodies to MACF1 (ab117418, RRID:
AB_10898474; Abcam), TOP2β (MAB6348, RRID:AB_10889629;
R&D Systems; 109524, RRID:AB_10859793; Abcam), Integrin α7
(sc-27706, RRID:AB_2265042; Santa Cruz Biotechnology),MAP1b
(ab11266, RRID:AB_297884; Abcam) or Synapsin (106002, RRID:
AB_887804; Synaptic Systems), and AChRs were labeled with
Alexa Fluor 594–α-BGT (Invitrogen). Images were acquired
with a Zeiss LSM 700 confocal microscope equipped with a 40×
(1.4 NA) objective. Hindlimb muscles were denervated by cut-
ting the sciatic nerve, as described previously by Simon et al.
(1992), 1 wk before the dissection.
Diaphragm muscles were dissected from E18.5 embryos and
postnatal mice in oxygenated L-15 medium. The muscles were
pinned onto Sylgard-coated dissection dishes, fixed for 1.5 h in
1% PFA, and blocked for 1 h in PBS with 3% BSA (IgG free; Sigma-
Aldrich) and 0.5% Triton X-100 (PBT). Primary antibodies,
diluted in PBT, were force-pipetted into the muscle, and the
muscles were incubated overnight at 4°C on an orbital shaker in
a humidified chamber. Diaphragm muscles were washed
10 times over the course of 5 h with PBT at room temperature
and rinsed in PBS before the muscle was whole-mounted in 50%
glycerol. Muscles from at least three mice of each genotype were
analyzed for each experiment. Diaphragm muscles were stained
with Alexa Fluor 488–conjugated α-BGT (Invitrogen) to label
AChRs and with antibodies to Neurofilament-L (171002, RRID:
AB_887743; Synaptic Systems), β-TUBIII (302302, RRID:
AB_10637424; Synaptic Systems), or Synapsin 1/2 (106002,
RRID:AB_887804; Synaptic Systems) to label motor axons and
nerve terminals, respectively (Kim and Burden, 2008). Images
were acquired with a Zeiss LSM 700 confocal microscope, and
the size of synapses, density of synaptic AChRs, and colocaliza-
tion (Synapsin/AChRs) from at least three mice were measured
as described previously (Jaworski and Burden, 2006). We de-
fined small synapses as those that were ≥1 SD smaller than the
mean size of synapses in Macf1f/+ control mice. Fragmented
synapses contained five or fewer fragments, as defined by others
(Valdez et al., 2010). The Wilcoxon–Mann–Whitney test was
used to determine statistical significance and was conducted
using GraphPad Prism 6.0 software.
Isolation and staining single muscle fibers
Tibialis anterior and lumbrical muscles were dissected in oxy-
genated L-15 medium and pinned to a Sylgard-coated dish and
fixed in 2% PFA (in PBS) for 2 h. After several rinses in PBS, one
to three myofibers were manually teased with fine forceps
(Ralston et al., 1999). Fixed myofibers were blocked for 2 h at
room temperature in PBS containing 5% BSA, 1% normal goat
serum, and 0.04% saponin. Fibers were then incubated with
primary antibodies for 2 h at room temperature (or overnight at
4°C), washed three times for 5 min with PBS containing 0.04%
saponin, incubated with secondary antibodies for 2 h at room
temperature, washed again, counterstained with Hoechst 33342
(4082S, RRID:AB_10626776; Cell Signaling Technology), and
mounted in VectaShield (Vector Laboratories). Antibodies to
Synapsin (106002, RRID:AB_887804; Synaptic Systems) were
used to mark synaptic vesicles in nerve terminals. We used
antibodies to MAP1b (ab11266, RRID:AB_297884; Abcam), EB1
(610534, RRID:AB_397891; BD Biosciences), Vinculin (V4505,
RRID:AB_477617; Sigma-Aldrich), α-TUB (05–829, RRID:
AB_310035; Millipore), and β-TUB (T5293, RRID:AB_477580;
Sigma-Aldrich) to label these MT- and actin-binding proteins.
The postsynaptic membrane was visualized by staining with
Alexa Fluor 488–α-BGT (Invitrogen), antibodies to Rapsyn
(MA1-746, RRID:AB_2177611; Thermo Fisher Scientific), and
antibodies to MACF1 (ab117418, RRID:AB_10898474; Abcam).
We quantified the number of synaptic and perisynaptic my-
onuclei by staining optically sectioned dissected single myofibers
with antibodies to Synapsin 1/2 (106002, RRID:AB_887804;
Synaptic Systems) and with a nuclear stain, Hoechst 33342
(4082S, RRID:AB_10626776; Cell Signaling Technology). This
procedure allowed us to distinguish myofiber subsynaptic nu-
clei from Schwann cell nuclei as described previously (Grady
et al., 2005).
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Histology of muscle sections
Tibialis anterior muscles were fixed in 4% PFA (in PBS) for 72 h,
dehydrated, and embedded in paraffin. 5-µm sections were
stained with hematoxylin and eosin. Images were captured us-
ing a Zeiss Axiophot microscope. Cross-sectional areas of
tibialis anterior muscles, the number of myofibers per area
(40,000 µm2), and the number of central nuclei were measured
using ImageJ software. The Wilcoxon–Mann–Whitney test was
used to determine statistical significance and was conducted
using GraphPad Prism 6.0 software. Muscles were prepared for
electron microscopy as described previously (Wang et al., 2005;
Friese et al., 2007).
Induction of AChR clusters and podosomes by Laminin
35-mm tissue culture dishes were coated with 5 µg/ml poly-
ornithine (Sigma-Aldrich) in distilled water for 30 min and
air-dried. Engelbreth-Holm-Swarm laminin (10 µg/ml in L-15
medium supplemented with 0.2% NaHCO3; Invitrogen) was
applied to the polyornithine-coated dishes, which were incu-
bated overnight at 37°C. Following removal of the laminin so-
lution, myoblasts were plated and grown to 70% confluency
before they were switched to differentiation medium and al-
lowed to differentiate for 3–5 d. After a 45-min incubation with
Alexa Fluor 488–conjugated α-BGT (Invitrogen) to stain AChRs,
cells were washed in PBS and fixed in 1% PFA in PBS. Free al-
dehydes were blockedwith 0.1M glycine (pH 7.3), and cells were
incubated with primary antibodies overnight at 4°C in PBS with
4% BSA and 0.2% Triton X-100 (PBT2). Cells were washed three
times in PBS for 5 min, incubated for 2 h with secondary anti-
bodies in PBT2, washed three times in PBS for 5 min, and
mounted in VectaShield (Vector Labs).
Agrin-induced formation of AChR clusters in
primary myotubes
Myoblasts were isolated from E17.5–18.5 embryos and grown in
culture as described previously (Reme´dio et al., 2016). Myotubes
were treated for 8 h with 500 pM Agrin (R&D Systems), rinsed
three times in PBS, and fixed for 10 min with 1% PFA (in PBS).
After washing twice for 10 min in PBS, the cultures were in-
cubated in 0.1 M glycine (in PBS) for 10min, rinsed twice in PBS,
and incubated for 30 min in PBS with 1% BSA. Cultures were
incubated with Alexa Fluor 594–α-BGT (1:1,000, in 1% BSA-PBS;
Invitrogen) for 1 h, washed in PBS (three times for 30 min),
permeabilized with PBS containing 0.1% Triton X-100 for 5 min,
stained with antibodies to myosin heavy chain (in PBS with 1%
BSA; M4276, RRID:AB_477190; Sigma-Aldrich) overnight at 4°C
in PBS with 4% BSA, washed three times in PBS for 5 min, in-
cubated for 2 h with secondary antibodies in 4% BSA-PBS,
washed three times in PBS for 5 min, and mounted in Vecta-
Shield (Vector Labs). Images were captured using a Zeiss LSM
700 confocal microscope, and the number and size of AChR
clusters were determined using ImageJ software, as described
previously (Wang et al., 2005; Friese et al., 2007). We analyzed
triplicate cultures from three mice, and >40 AChR clusters in
each culture dish were analyzed. The Wilcoxon–Mann–Whitney
test was used to determine statistical significance and was
conducted using GraphPad Prism 6.0 software.
Image analysis
Images were acquired with a Zeiss LSM 700 or LSM 800 con-
focal microscope. Optical sections were acquired with a confocal
laser scanning microscope Zeiss LSM 880 equipped with an
Airyscan detection unit. To maximize the resolution enhance-
ment, we used a high NA oil immersion α Plan-Apochromat
100×/1.46 Oil Corr M27 objective (Zeiss). All images were col-
lected using Immersol 518F immersion media with a matched
refractive index (nc = 1.518; 30°C; Zeiss). Detector gain and pixel
dwell times were adjusted for each dataset, keeping them at
their lowest values in order to avoid saturation and bleaching.
Laser intensity values at the sample plane were measured with a
Microscope Slide Thermal Sensor (Thorlabs). Zen Black 2.1
(Version 13.0.0.0) software, which processes each of the 32 Airy
detector channels separately by performing filtering, deconvo-
lution, and pixel reassignment, was used to process the acquired
datasets and obtain images with enhanced spatial resolution. To
determine the degree of colocalization between proteins stained
with spectrally distinct fluorophores, we calculated the Pearson’s
correlation coefficient (PCC) as described (Costes et al., 2004).
Whole exome sequencing and human data analysis/sharing
DNA samples isolated from blood were prepared for exome se-
quencing using the Nextera Exome Enrichment method from
Illumina, using 50 ng of gDNA. Whole exome sequencing sam-
ples were sequenced on Illumina HiSeq 2500 instruments. Reads
were aligned to NCBI Build 37 of the human reference sequence
using Burrows-Wheeler Aligner 0.7.8, and variants were iden-
tified using Genome Analysis Toolkit HaplotypeCaller 3.6 gen-
erating a genomic Variant Call Format. All positions with
genotype quality score (GQ) > 19 and overall read depth (DP) > 7
were uploaded onto the RD-Connect Genome-Phenome Analysis
Platform (https://platform.rd-connect.eu/genomics/). Data were
initially analyzed applying standard filtering criteria (high/
moderate variant effect predictor andminor allele frequency < 0.01)
and a gene list of all known CM-causing genes. As no variants in
known CM genes were identified, the full genome was inter-
rogated in search of a novel candidate gene. Candidate variants
were confirmed and segregated in unaffected family members
by Sanger sequencing. To identify additional cases, a large co-
hort of more than 3,000 exomes was interrogated for homo-
zygous or compound heterozygous rare variants in MACF1.
Electrophysiology
Intracellular recordings were performed in lumbrical muscles
from muscle-conditional Macf1 mutant mice (n = 4, Hsa::Cre;
Macf1f/-) and their littermate controls (n = 4, Macf1f/+) at 7 to ∼8
mo of age, using methods described previously (Chen et al.,
2010; Sugiura et al., 2011). Briefly, lumbrical muscles with
plantar nerves attached were acutely isolated in oxygenated
(95% O2, 5% CO2) Ringer’s solution (136.8 mM sodium chloride,
5 mM potassium chloride, 12 mM sodium bicarbonate, 1 mM
sodium phosphate, 1 mM magnesium chloride, 2 mM calcium
chloride, and 11 mM D-glucose, pH 7.3; Liley, 1956). Endplate
regions, identified under a water-immersion objective (Olympus
BX51WI), were impaled with glass micropipettes (resistance
20–40 MΩ) filled with 2 M potassium citrate and 10 mM
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potassium chloride. EPPs were elicited by supra-threshold
stimulation (2 V, 0.1 ms) of the nerve via a suction electrode
connected to an extracellular stimulator (SD9; Grass-Telefactor).
A muscle-specific sodium channel blocker, μ-Conotoxin GIIIB
(2 µM; Peptides International), was added to the bath solution
30 min before recording to prevent muscle contraction during
recording. mEPPs and EPPs were acquired using an intracellular
amplifier (AxoClamp-2B) and digitized with Digidata 1332
(Molecular Devices). Data were analyzed with pClamp 10.7
(Molecular Devices) and Mini Analysis Program (Synaptosoft,
Inc.). To determine the quantal content, a direct method was
applied by dividing EPPs over mEPPs as described previously
(Boyd and Martin, 1956; Hubbard et al., 1969). The Wilcoxon–
Mann–Whitney test was used to determine statistical signifi-
cance and was conducted using GraphPad Prism 6.0 software.
Behavior
Grip strength was measured using a grip strength apparatus
(Bioseb), which measures both forelimb and all-limb grip
strength. To measure forelimb grip strength, the mouse was
positioned in the center of a metal grid and held gently at the
base of its tail so that only its front paws were able to grip the
grid. The mouse was pulled back steadily, until the forelimb grip
was released from the grid. The grip strength meter digitally
displayed the maximum force applied (in grams) as the grasp
was released. For the all-limb measurements, the mouse was
allowed to grip the grid with both forelimbs and hindlimbs, and
the mouse was pulled back steadily, until the mouse lost grip
with the grid. The means of six consecutive trials of both fore-
limb and all-limb measurements were taken as an index of
forelimb or all-limb grip strength. Mice were given an interval
of 10–15 s between trials and 1–3 h between forelimb and all-limb
testing. Body weight was determined after all grip strength
measurements to analyze for potential covariability. To enhance
the robustness and reliability of the grip strength assessment, all
measurements were taken by the same experimenter (Mandillo
et al., 2008).
Motor function of male and female mice at P90 and P180 was
assessed on a rotarod (AccuRotor four-channel, Omnitech
Electronics, Inc.). Mice were placed on the rotarod (3.0-cm ro-
tating cylinder) rotating at 2.5 rpm, and the speed of rotation
was increased linearly to 40 rpm over the course of 5 min. The
time to fall from the rod was measured. Each mouse was sub-
jected to three trials in 5-min intervals, and we recorded the
longest latency to fall from the three trials. The Wilcoxon–
Mann–Whitney test was used to determine statistical signifi-
cance and was conducted using GraphPad Prism 6.0 software.
Online supplemental material
In Fig. S1, ARMS, Integrin α7, and Topoisomerase2β are enriched
at the neuromuscular synapse. In Fig. S2, MACF1 is not essential
for the Agrin-stimulated formation of AChRs clusters in muscle
primary cultures. In Fig. S3, neuromuscular synapses in Macf1
muscle-conditional mutant mice are deteriorated in both tibialis
anterior and lumbrical muscles at P365. In Fig. S4, MAP1b coi-
solates with AChRs in a Rapsyn-dependent manner. Table S1
shows a summary of Rapsyn-dependent AChR partners that
were identified by MS both in muscle tissue and in cultured
myotubes. Table S2 shows Rapsyn-dependent AChR partners
that were identified by MS in muscle tissue using Digitonin as a
detergent.
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